INS and cardiomyopathy: Hyperinsulinemia including iatrogenic hyperinsulinemia, particularly if insulin is inadequately titrated, is associated with adverse events that increase the risk of cardiomyopathy, induce endothelial dysfunction, promote atherosclerosis, cause renal retention of sodium and water and increase vasoreactivity and blood pressure [21].